Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential?
Wedgewood Partners, an investment management company, released its fourth-quarter 2025 investor letter.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 22,632 | $1,929,378 | 0.01% | |
| 2. | Bourgeon Capital John Zaro | 3,007 | $256,347 | 0.04% | |
| 3. | Bayforest Capital Theodoros Tsagaris | 2,990 | $254,898 | +38% | 0.19% |
| 4. | Sivik Global Healthcare Krishen Sud | 35,000 | $2,984 | 0.87% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.74 | 580 | $49,752.72 | 3,268 | 2024-05-06 | Filing | |
| $112.23 | 1,500 | $168,345.00 | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | $270,300.00 | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | $328,486.86 | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | $745,205.88 | 43,690 | 2016-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.70 | 1,019 | $87,332.07 | 22,002 | 2026-01-09 | Filing | |
| $85.98 | 8,708 | $748,707.74 | 31,870 | 2026-01-06 | Filing | |
| $84.62 | 2,632 | $222,721.42 | 40,578 | 2026-01-06 | Filing | |
| $83.74 | 5,900 | $494,066.00 | 38,970 | 2025-12-12 | Filing | |
| $83.79 | 5,486 | $459,681.79 | 44,870 | 2025-12-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,734,946 | $659,404,081 | 1.41% | |
| 2. | 4,800,000 | $409,200,000 | 4.39% | |
| 3. | 3,642,618 | $312,645,903 | 0.27% | |
| 4. | 2,286,298 | $194,906,905 | 0.27% | |
| 5. | 1,569,237 | $134,141,372 | 0.22% |
News See All
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript October 30, 2025Edwards Lifesciences Corporation beats earnings expectations.
Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results
Edwards Lifesciences Corporation (NYSE:EW) ranks among the best medical device stocks to invest in.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
Edwards Lifesciences Corporation (EW): A Bull Case Theory
We came across a bullish thesis on Edwards Lifesciences Corporation on Natan’s Substack. In this article, we will summarize the bulls’ thesis on EW.
Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS)
In an announcement on August 29, 2025, Edwards Lifesciences Corporation (NYSE:EW) expressed its positive response to newly updated ESC/EACTS guidelines for severe aortic stenosis (AS), which recommend...
14 Tech Stocks to Sell Now According to Ken Fisher
On September 4, 2025, global markets were mostly higher as cooling U.S. labor data and dovish Federal Reserve comments pointed to a possible rate cut this month.
Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus
Edwards Lifesciences Corporation (NYSE:EW) is one of the top stock picks in Ken Griffin’s portfolio.
Ken Griffin Stock Portfolio: Top 12 Stock Picks
Always play offense and invest opportunistically during the market selloff.
Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here’s Why
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.